Vertex Pharmaceuticals Incorporated (LON:0QZU)
London flag London · Delayed Price · Currency is GBP · Price in USD
469.42
+5.50 (1.19%)
At close: Jul 16, 2025

Vertex Pharmaceuticals Market Cap

Vertex Pharmaceuticals has a market cap or net worth of 87.83 billion as of July 18, 2025. Its market cap has decreased by -8.73% in one year.

Market Cap
87.83B
Enterprise Value
80.60B
Revenue
8.59B
Ranking
n/a
PE Ratio
n/a
Stock Price
469.42

Market Cap Chart

Since July 24, 1991, Vertex Pharmaceuticals's market cap has increased from 51.21M to 87.83B, an increase of 171,395.10%. That is a compound annual growth rate of 24.48%.

History

DateMarket Cap% Change
Jul 17, 202588.70B7.08%
Dec 31, 202482.84B0.64%
Dec 29, 202382.31B33.80%
Dec 30, 202261.52B49.20%
Dec 31, 202141.23B-8.40%
Dec 31, 202045.01B5.89%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 31, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
AstraZeneca159.91B
GSK plc57.12B
Haleon32.24B
Smith & Nephew9.80B
ConvaTec Group4.94B
Hikma Pharmaceuticals4.40B
HUTCHMED (China)2.16B
Genus1.59B
Market Cap Rankings